Metabolic clearance of biologically active luteinizing hormone in man

Johannes D Veldhuis, F. Fraioli, A. D. Rogol, M. L. Dufau

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

The plasma metabolic clearance of biologically active luteinizing hormone (bioactive LH) was studied using the rat interstitial cell testosterone (RICT) bioassay in six hypogonadotropic men after single bolus injection of highly purified human LH and during continuous steady-state infusions of three graded doses of LH. The LH bolus disappearance curves provided estimates of metabolic clearance rates (MCR) of 24.1 ± 4.7 (±SD) ml/min for bioactive LH vs 56.2 ± 12 ml/min for immunoactive LH in the same men (P = 0.03). A lower MCR of bioactive LH compared with immunoactive LH was also observed during continuous infusions of physiological doses of LH; for example, the mean steady-state MCRs for bioactive and immunoactive LH were, respectively, 26.1 ± 3.1 and 34.2 ± 3.2 ml/min (P = 0.02). Moreover, the stepped-dose infusion regimens permitted us to demonstrate that increasing doses of pure human LH resulted in progressive and parallel decreases in the apparent MCRs of both bioactive and immunoactive LH. Based on the respective steady-state MCRs calculated at physiological plasma concentrations of immunoactive and bioactive LH, we estimate a mean endogenous production rate for bioactive hormone of 1,937 IU/24 h, and for immunoactive LH of 589 IU/24 h in normal men. These results indicate that previous estimates of LH production rates from immunoassay data alone markedly underestimate the quantity of biologically active hormone secreted in man.

Original languageEnglish (US)
Pages (from-to)1122-1128
Number of pages7
JournalJournal of Clinical Investigation
Volume77
Issue number4
StatePublished - 1986
Externally publishedYes

Fingerprint

Luteinizing Hormone
Metabolic Clearance Rate
Hormones
Immunoassay
Biological Assay
Testosterone
Injections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Veldhuis, J. D., Fraioli, F., Rogol, A. D., & Dufau, M. L. (1986). Metabolic clearance of biologically active luteinizing hormone in man. Journal of Clinical Investigation, 77(4), 1122-1128.

Metabolic clearance of biologically active luteinizing hormone in man. / Veldhuis, Johannes D; Fraioli, F.; Rogol, A. D.; Dufau, M. L.

In: Journal of Clinical Investigation, Vol. 77, No. 4, 1986, p. 1122-1128.

Research output: Contribution to journalArticle

Veldhuis, JD, Fraioli, F, Rogol, AD & Dufau, ML 1986, 'Metabolic clearance of biologically active luteinizing hormone in man', Journal of Clinical Investigation, vol. 77, no. 4, pp. 1122-1128.
Veldhuis JD, Fraioli F, Rogol AD, Dufau ML. Metabolic clearance of biologically active luteinizing hormone in man. Journal of Clinical Investigation. 1986;77(4):1122-1128.
Veldhuis, Johannes D ; Fraioli, F. ; Rogol, A. D. ; Dufau, M. L. / Metabolic clearance of biologically active luteinizing hormone in man. In: Journal of Clinical Investigation. 1986 ; Vol. 77, No. 4. pp. 1122-1128.
@article{4fb96f1ebb9540b98eeec9fc1eea3666,
title = "Metabolic clearance of biologically active luteinizing hormone in man",
abstract = "The plasma metabolic clearance of biologically active luteinizing hormone (bioactive LH) was studied using the rat interstitial cell testosterone (RICT) bioassay in six hypogonadotropic men after single bolus injection of highly purified human LH and during continuous steady-state infusions of three graded doses of LH. The LH bolus disappearance curves provided estimates of metabolic clearance rates (MCR) of 24.1 ± 4.7 (±SD) ml/min for bioactive LH vs 56.2 ± 12 ml/min for immunoactive LH in the same men (P = 0.03). A lower MCR of bioactive LH compared with immunoactive LH was also observed during continuous infusions of physiological doses of LH; for example, the mean steady-state MCRs for bioactive and immunoactive LH were, respectively, 26.1 ± 3.1 and 34.2 ± 3.2 ml/min (P = 0.02). Moreover, the stepped-dose infusion regimens permitted us to demonstrate that increasing doses of pure human LH resulted in progressive and parallel decreases in the apparent MCRs of both bioactive and immunoactive LH. Based on the respective steady-state MCRs calculated at physiological plasma concentrations of immunoactive and bioactive LH, we estimate a mean endogenous production rate for bioactive hormone of 1,937 IU/24 h, and for immunoactive LH of 589 IU/24 h in normal men. These results indicate that previous estimates of LH production rates from immunoassay data alone markedly underestimate the quantity of biologically active hormone secreted in man.",
author = "Veldhuis, {Johannes D} and F. Fraioli and Rogol, {A. D.} and Dufau, {M. L.}",
year = "1986",
language = "English (US)",
volume = "77",
pages = "1122--1128",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Metabolic clearance of biologically active luteinizing hormone in man

AU - Veldhuis, Johannes D

AU - Fraioli, F.

AU - Rogol, A. D.

AU - Dufau, M. L.

PY - 1986

Y1 - 1986

N2 - The plasma metabolic clearance of biologically active luteinizing hormone (bioactive LH) was studied using the rat interstitial cell testosterone (RICT) bioassay in six hypogonadotropic men after single bolus injection of highly purified human LH and during continuous steady-state infusions of three graded doses of LH. The LH bolus disappearance curves provided estimates of metabolic clearance rates (MCR) of 24.1 ± 4.7 (±SD) ml/min for bioactive LH vs 56.2 ± 12 ml/min for immunoactive LH in the same men (P = 0.03). A lower MCR of bioactive LH compared with immunoactive LH was also observed during continuous infusions of physiological doses of LH; for example, the mean steady-state MCRs for bioactive and immunoactive LH were, respectively, 26.1 ± 3.1 and 34.2 ± 3.2 ml/min (P = 0.02). Moreover, the stepped-dose infusion regimens permitted us to demonstrate that increasing doses of pure human LH resulted in progressive and parallel decreases in the apparent MCRs of both bioactive and immunoactive LH. Based on the respective steady-state MCRs calculated at physiological plasma concentrations of immunoactive and bioactive LH, we estimate a mean endogenous production rate for bioactive hormone of 1,937 IU/24 h, and for immunoactive LH of 589 IU/24 h in normal men. These results indicate that previous estimates of LH production rates from immunoassay data alone markedly underestimate the quantity of biologically active hormone secreted in man.

AB - The plasma metabolic clearance of biologically active luteinizing hormone (bioactive LH) was studied using the rat interstitial cell testosterone (RICT) bioassay in six hypogonadotropic men after single bolus injection of highly purified human LH and during continuous steady-state infusions of three graded doses of LH. The LH bolus disappearance curves provided estimates of metabolic clearance rates (MCR) of 24.1 ± 4.7 (±SD) ml/min for bioactive LH vs 56.2 ± 12 ml/min for immunoactive LH in the same men (P = 0.03). A lower MCR of bioactive LH compared with immunoactive LH was also observed during continuous infusions of physiological doses of LH; for example, the mean steady-state MCRs for bioactive and immunoactive LH were, respectively, 26.1 ± 3.1 and 34.2 ± 3.2 ml/min (P = 0.02). Moreover, the stepped-dose infusion regimens permitted us to demonstrate that increasing doses of pure human LH resulted in progressive and parallel decreases in the apparent MCRs of both bioactive and immunoactive LH. Based on the respective steady-state MCRs calculated at physiological plasma concentrations of immunoactive and bioactive LH, we estimate a mean endogenous production rate for bioactive hormone of 1,937 IU/24 h, and for immunoactive LH of 589 IU/24 h in normal men. These results indicate that previous estimates of LH production rates from immunoassay data alone markedly underestimate the quantity of biologically active hormone secreted in man.

UR - http://www.scopus.com/inward/record.url?scp=0022551868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022551868&partnerID=8YFLogxK

M3 - Article

C2 - 3958184

AN - SCOPUS:0022551868

VL - 77

SP - 1122

EP - 1128

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -